EFX
30
-8
DG
8
-2
PBI
56
-2
EW
32
3
CRM
60
-7
WU
24
4
DGX
48
11
FITB
60
-5
PEP
39
-9
EMR
71
-3
GLW
45
-3
MTCH
20
-8
ROP
53
-9
CMI
64
-3
T
48
3
AMT
37
3
DAL
84
-3
NOC
41
9
KR
36
-6
UAL
83
-2
EFX
30
-8
DG
8
-2
PBI
56
-2
EW
32
3
CRM
60
-7
WU
24
4
DGX
48
11
FITB
60
-5
PEP
39
-9
EMR
71
-3
GLW
45
-3
MTCH
20
-8
ROP
53
-9
CMI
64
-3
T
48
3
AMT
37
3
DAL
84
-3
NOC
41
9
KR
36
-6
UAL
83
-2
Financhill
Back

BondBloxx Bloomberg Two YrTrgDurUSTrsETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

XTWO
BondBloxx Bloomberg Two YrTrgDurUSTrsETF

Last Price:
49.16
Seasonality Move:
0.24%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
BondBloxx Bloomberg Two YrTrgDurUSTrsETF (XTWO) is a Sell

Is BondBloxx Bloomberg Two YrTrgDurUSTrsETF a Buy, Sell or Hold?

  • The current BondBloxx Bloomberg Two YrTrgDurUSTrsETF [XTWO] share price is $49.12. The Score for XTWO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • XTWO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTWO Stock Price Chart

What is BondBloxx Bloomberg Two YrTrgDurUSTrsETF's stock price today?

  • The BondBloxx Bloomberg Two YrTrgDurUSTrsETF share price today is $49.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTWO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

XTWO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 36.34 Sell
Chaikin Money Flow: 2102 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.15 - 49.45) Sell
Bollinger Bands (100): (49.13 - 49.73) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

XTWO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.12 Sell
20-day SMA: 49.25 Sell
50-day SMA: 49.53 Sell
200-day SMA: 49.17 Sell
8-day EMA: 49.14 Sell
20-day EMA: 49.24 Sell
50-day EMA: 49.38 Sell
200-day EMA: 49.28 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BondBloxx Bloomberg Two YrTrgDurUSTrsETF Earnings Growth & XTWO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BondBloxx Bloomberg Two YrTrgDurUSTrsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):